Non-inferiority trials have become an essential instrument in clinical research, particularly when the goal is to demonstrate that an experimental treatment is not unacceptably worse than an ...
The US Food and Drug Administration (FDA) on Monday finalized guidance to pharmaceutical and biotech sponsors looking for more advice on when non-inferiority studies demonstrating effectiveness of an ...
Randomized controlled trial of the efficacy of lymph node dissection on stage IIICr of cervical cancer (CQGOG0103). Background: Minimally invasive surgery (MIS) is associated with improved ...
Case Examples of Bayesian Study Designs Used to Accelerate Assessments of Device Safety and Efficacy in SHD Receive the the latest news, research, and presentations from major meetings right to your ...
Moura Junior, Valdery, Susanna Gallani, Peter Hadar, Maria A. Donahue, Andrea Thurler, Lipika Samal, Yousif Alsaadi, Hadi Kobaissi, Gaurdia Banister, Rebecca Mishuris ...
Please provide your email address to receive an email when new articles are posted on . Tapering regimens were linked to significantly higher flare risk among patients in RA remission. The results ...
Novartis NVS reported positive top-line data from a late-stage study of its investigational new malaria treatment candidate, KLU156 (ganaplacide/lumefantrine, or ...
ONS-5010 shows non-inferiority to Lucentis at 12 weeks; BLA resubmission planned for Q1 2025, with $20.4M in proceeds expected. ONS-5010 demonstrated non-inferiority to ranibizumab at week 12, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results